Evaluation of the cost-effectiveness of coronary stenting: A societal perspective

American Heart Journal

Volumn 137, Issue 5, 1999, Pages

  Cohen, David J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE; WARFARIN; ANTICOAGULANT AGENT;

ATHERECTOMY; CONFERENCE PAPER; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; EXCIMER LASER; HEALTH CARE COST; HOSPITAL COST; HUMAN; PRIORITY JOURNAL; RESOURCE ALLOCATION; TRANSLUMINAL CORONARY ANGIOPLASTY; ARTICLE; CORONARY ARTERY DISEASE; COST; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; STENT; UNITED STATES;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HOSPITAL COSTS; HUMANS; STENTS; UNITED STATES; WARFARIN;

EID: 0033129046     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70448-5     Document Type: Conference Paper

References (24)

1. 1. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
2. 2. RITA-2 trial participants. Coronary angioplasty versus medical therapy For angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-8.
3. 3. Wong JB, Sonnenberg FA, Salem DN, et al. Myocardial revascularization for chronic stable angina: analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 1990;113:852-71.
4. 4. Dick RJ, Popma JJ, Muller DW, et al. In-hospital costs associated with new percutaneous coronary devices. Am J Cardiol 1991;68:879-85.
5. 5. Cohen DJ, Breall JA, Ho KKL, et al. The economics of elective coronary revascularization: comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting, and bypass surgery. J Am Coll Cardiol 1993;22:1052-9.
6. 6. Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
7. 7. Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336: 817-22.
8. 8. Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-7.
9. 9. Topol EJ. Caveats about elective coronary stenting. N Engl J Med 1994;331:539-41.
10. 10. Topol EJ. The stentor and the sea change. Am J Cardiol 1995;76: 307-8.
11. 11. Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-78.
12. 12. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
13. 13. Karillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Multicenter Registry. Circulation 1996;94:1519-27.
14. 14. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996;334:1084-9.
15. 15. Ellis SG, Miller DP, Brown KJ, et al. In-hospital cost of percutaneous coronary revascularization: critical determinants and implications. Circulation 1995;92:741-7.
16. 16. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and 1-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial. Circulation 1995;92: 2480-7.
17. 17. Peterson ED, Cowper PA, Zidar JP, et al. In-hospital costs of coronary stenting (with or without coumarin) compared with angioplasty [abstract]. Circulation 1996;94:1-325.
18. 18. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
19. 19. Sukin CA, Baim DS, Caputo RP, et al. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol 1997;79:275-80.
20. 20. Fischman DL, Savage MP, Penn I, et al. High pressure inflation in conjunction with ticlopidine and aspirin following coronary stent placement: results of the STRESS III trial [abstract]. J Am Coll Cardiol 1997;29:171A.
21. 21. Legrand V, Serruys PW, Emanuelsson H, et al. BENESTENT II trial: final results of visitor I: a 15-day follow-up [abstract]. J Am Coll Cardiol 1997;29:170A.
22. 22. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412-22.
23. 23. Cohen DJ, Breall JA, Ho KKL, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: use of a decision-analytic model. Circulation 1994;89:1859-74.
24. 24. Stason WB, Weinstein MC. Allocation of resources to manage hypertension. N Engl J Med 1977;296:732-9.